Clinical trials
Recruiting Phase 2 Immune System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Asger Sverrild | 1 |
| Cogent Biosciences, Inc. | 1 |
| Deciphera Pharmaceuticals, LLC | 1 |
| Inmagene LLC | 1 |
| Jade Biosciences, Inc. | 1 |
| Joseph Oved | 1 |
| Orca Biosystems, Inc. | 1 |
| Qu Biologics Inc. | 1 |
| Queen Mary University of London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 15 |
| Autoimmune Diseases | 7 |
| Glomerulonephritis | 3 |
| Glomerulonephritis, IGA | 3 |
| Kidney Diseases | 3 |
| Common Variable Immunodeficiency | 2 |
| Graft vs Host Disease | 2 |
| Hematologic Diseases | 2 |
| Hematologic Neoplasms | 2 |
| Leukemia | 2 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.